Form 4: Health Catalyst Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Kevin Lee Freeman, Chief Commercial Officer of Health Catalyst, sold 10,800 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 3, 2025, Kevin Lee Freeman, the Chief Commercial Officer of Health Catalyst, Inc. (HCAT), sold 10,800 shares of common stock.
- The sale was executed at a price of $4.5771 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of the issuer's restricted stock units.
- Following the transaction, Freeman directly owns 384,412 shares of Health Catalyst common stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, not indicative of positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. This transaction is a standard 'sell to cover' arrangement, common in equity compensation plans.
Stakeholder Impact
- The sale has a minimal impact on shareholders as it is related to tax obligations and not a discretionary trade.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of stock sale transaction |
| 03/04/2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.